199 related articles for article (PubMed ID: 21786315)
21. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
Sumoza A; de Bisotti R; Sumoza D; Fairbanks V
Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
[TBL] [Abstract][Full Text] [Related]
23. [Blood transfusion assessment to 112 homozygous sickle-cell disease patients in university hospital of Brazzaville].
Dokekias AE; Ossini LN; Tsiba FO; Malanda F; Koko I; De Montalembert M
Transfus Clin Biol; 2009; 16(5-6):464-70. PubMed ID: 19369104
[TBL] [Abstract][Full Text] [Related]
24. Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease.
Choi J; Markantonis JE; De Simone N; Nero A; Kim J; Sarode R
J Clin Apher; 2023 Dec; 38(6):677-684. PubMed ID: 37525930
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
Uhlmann EJ; Shenoy S; Goodnough LT
Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
[TBL] [Abstract][Full Text] [Related]
26. Red blood cell exchange in children and adolescents with sickle cell disease.
Merlin E; Hequet O; Kanold J
Transfus Apher Sci; 2019 Apr; 58(2):136-141. PubMed ID: 30914240
[TBL] [Abstract][Full Text] [Related]
27. [Results of partial transfusion exchange in 42 homozygous sickle cell patients at university hospital of Brazzaville].
Dokekias AE; Basseila GB
Transfus Clin Biol; 2010 Oct; 17(4):232-41. PubMed ID: 20965766
[TBL] [Abstract][Full Text] [Related]
28. Partial Red Blood Cell Exchange in Children and Young Patients with Sickle Cell Disease: Manual Versus Automated Procedure.
Escobar C; Moniz M; Nunes P; Abadesso C; Ferreira T; Barra A; Lichtner A; Loureiro H; Dias A; Almeida H
Acta Med Port; 2017 Oct; 30(10):727-733. PubMed ID: 29268067
[TBL] [Abstract][Full Text] [Related]
29. Chronic transfusions in patients with sickle cell disease. Indications and problems.
Piomelli S
Am J Pediatr Hematol Oncol; 1985; 7(1):51-5. PubMed ID: 4037243
[TBL] [Abstract][Full Text] [Related]
30. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
31. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.
Scothorn DJ; Price C; Schwartz D; Terrill C; Buchanan GR; Shurney W; Sarniak I; Fallon R; Chu JY; Pegelow CH; Wang W; Casella JF; Resar LS; Berman B; Adamkiewicz T; Hsu LL; Ohene-Frempong K; Smith-Whitley K; Mahoney D; Scott JP; Woods GM; Watanabe M; Debaun MR
J Pediatr; 2002 Mar; 140(3):348-54. PubMed ID: 11953734
[TBL] [Abstract][Full Text] [Related]
32. Red blood cell exchange in children with sickle cell disease.
Elenga N; Vantilcke V; Martin E; Cuadro E; Selles P; Basset T
Int J Hematol; 2022 Jan; 115(1):107-113. PubMed ID: 34550539
[TBL] [Abstract][Full Text] [Related]
33. Automated red cell exchange procedures in patients with sickle cell disease.
Kozanoglu I; Boga C; Ozdogu H; Sezgin N; Kizilkilic E; Kural M
Transfus Apher Sci; 2007 Jun; 36(3):305-12. PubMed ID: 17584530
[TBL] [Abstract][Full Text] [Related]
34. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
[TBL] [Abstract][Full Text] [Related]
35. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
Aloni MN; LĂȘ PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
[TBL] [Abstract][Full Text] [Related]
37. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
[TBL] [Abstract][Full Text] [Related]
39. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
[TBL] [Abstract][Full Text] [Related]
40. Plasma exchange-A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction.
Webb CB; Yates SG; Sarode R; Kim J
Transfusion; 2023 Jul; 63(7):1384-1390. PubMed ID: 37317564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]